Surgery (HCC)

Dual HBV/HCV Infection Not Big Factor in Outcome

Published in Cancer Weekly, August 24th, 1998

Dual hepatitis B and C infection should not exclude hepatocellular carcinoma patients from surgery, according to a Taiwanese study comparing these patients to those with single etiology infections.

"Hepatic resection for hepatocellular carcinoma (HCC) in patients with dual hepatitis B virus (HBV) and hepatitis C virus (HCV) infections was associated with only slightly higher postoperative morbidity and mortality rates than in those with either virus infection; thus the risks were such that we recommend that the operation should not be denied to well-selected patients," Miin-Fu Chen and colleagues wrote ("Surgical Results in Patients with Dual Hepatitis B- and C-Related...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1998-08-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry